Rosenblum-Silverman-Sutton »

Alnylam Pharmaceuticals shares owned by Rosenblum-Silverman-Sutton

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Rosenblum-Silverman-Sutton from 13F filings

Historical chart of Rosenblum-Silverman-Sutton investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Rosenblum-Silverman-Sutton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Rosenblum-Silverman-Sutton

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.6M 37k 177.10
2023-06-30 $7.1M 37k 189.94
2023-03-31 $7.5M 38k 200.32
2022-12-31 $9.5M 40k 237.65
2022-09-30 $8.0M 43k 188.52
2022-06-30 $6.2M 43k 145.85
2022-03-31 $6.8M 42k 163.29
2021-12-31 $7.2M 42k 169.57
2021-09-30 $8.1M 43k 188.80
2021-06-30 $7.4M 43k 169.52
2021-03-31 $6.1M 43k 141.18
2020-12-31 $5.5M 42k 129.96
2020-09-30 $6.1M 42k 145.60
2020-06-30 $5.8M 39k 148.12
2020-03-31 $4.1M 38k 108.84